Hyaluronan and RHAMM in Wound Repair and the "cancerization" of Stromal Tissues

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Tolg, Cornelia ^a   McCarthy, James B ^b   Yazdani, Arjang ^c   Turley, Eva A ^a,c  

^a LONDON REGIONAL CANCER PROGRAM   (Canada)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONAN MEDIATED MOTILITY RECEPTOR; HYALURONIC ACID; UNCLASSIFIED DRUG; HERMES ANTIGEN; HYALURONAN-MEDIATED MOTILITY RECEPTOR; SCLEROPROTEIN;

BREAST CANCER; CANCER GROWTH; CARCINOGENESIS; CELL COMPARTMENTALIZATION; FIBROBLAST; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR WEIGHT; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; TISSUE REPAIR; TUMOR MICROENVIRONMENT; WOUND HEALING; ANIMAL; METABOLISM; PATHOLOGY; STROMA CELL;

ANIMALS; ANTIGENS, CD44; CARCINOGENESIS; EXTRACELLULAR MATRIX PROTEINS; HUMANS; HYALURONIC ACID; SIGNAL TRANSDUCTION; STROMAL CELLS; WOUND HEALING;

EID: 84926681837     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/103923     Document Type: Review

References (218)

1. P. L. Ballard, L. W. Gonzales, R. I. Godinez et al., "Surfactant composition and function in a primate model of infant chronic lung disease: A Effects of inhaled nitric oxide, " Pediatric Research, vol. 59, no. 1, pp. 157-162, 2006.
2. M. Schäfer and S.Werner, "Cancer as an overhealing wound: A n old hypothesis revisited, Nature ReviewsMolecular Cell Biology, vol. 9, no. 8, pp. 628-638, 2008.
3. M. Veiseh and E. A. Turley, "Hyaluronan metabolism in remodeling extracellular matrix: A probes for imaging and therapy of breast cancer, " Integrative Biology, vol. 3, no. 4, pp. 304-315, 2011.
4. J. S. Byun and K. Gardner, "Wounds that will not heal: A Pervasive cellular reprogramming in cancer, " American Journal of Pathology, vol. 182, no. 4, pp. 1055-1064, 2013.
5. X. Meng, J. Zhong, S. Liu, M. Murray, and A. M. Gonzalez- Angulo, "A new hypothesis for the cancer mechanism, " Cancer and Metastasis Reviews, vol. 31, no. 1-2, pp. 247-268, 2012.
6. R. A. Mukhtar, O. Nseyo, M. J. Campbell, and L. J. Esserman, "Tumor-associated macrophages in breast cancer as potential biomarkers for new treatments and diagnostics, " Expert Review of Molecular Diagnostics, vol. 11, no. 1, pp. 91-100, 2011.
7. M. V. Dieci, M. Arnedos, F. and re, and J. C. Soria, "Fibroblast growth factor receptor inhibitors as a cancer treatment: A from a biologic rationale to medical perspectives, " Cancer Discovery, vol. 3, no. 3, pp. 264-279, 2013.
8. K. Polyak, "Pregnancy and breast cancer: A the other side of the coin, " Cancer Cell, vol. 9, no. 3, pp. 151-153, 2006.
9. D. C. Radisky and L. C. Hartmann, "Mammary involution and breast cancer risk: A transgenic models and clinical studies, " Journal ofMammary Gland Biology and Neoplasia, vol. 14, no. 2, pp. 181-191, 2009.
10. S. Kobayashi, H. Sugiura, Y. and o et al., "Reproductive history and breast cancer risk, " Breast Cancer, vol. 19, no. 4, pp. 302-308, 2012.
11. C. Ercan, P. J. van Diest, and M. Vooijs, "Mammary development and breast cancer: A the role of stem cells, " Current Molecular Medicine, vol. 11, no. 4, pp. 270-285, 2011.
12. T. Stein, N. Salomonis, D. S. Nuyten, M. J. van de Vijver, and B. A. Gusterson, "A mouse mammary gland involution mRNA signature identifies biological pathways potentially associated with breast cancer metastasis, " Journal of Mammary Gland Biology and Neoplasia, vol. 14, no. 2, pp. 99-116, 2009.
13. J. Monks and P. M. Henson, "Differentiation of the mammary epithelial cell during involution: A Implications for breast cancer, " Journal of Mammary Gland Biology and Neoplasia, vol. 14, no. 2, pp. 159-170, 2009.
14. F. Lanigan, D. OConnor, F. Martin, and W. M. Gallagher, "Molecular links between mammary gland development and breast cancer, " Cellular and Molecular Life Sciences, vol. 64, no. 24, pp. 3159-3184, 2007.
15. P. Schedin, J. OBrien, M. Rudolph, T. Stein, and V. Borges, "Microenvironment of the involuting mammary gland mediates mammary cancer progression, " Journal ofMammary Gland Biology and Neoplasia, vol. 12, no. 1, pp. 71-82, 2007.
16. J. W. Penn, A. O. Grobbelaar, and K. J. Rolfe, "The role of the TGF-beta family in wound healing, burns and scarring: A review, " International Journal of Burns and Trauma, vol. 2, no. 1, pp. 18-28, 2012.
17. S. H. Phan, "Genesis of the myofibroblast in lung injury and fibrosis, " Proceedings of the AmericanThoracic Society, vol. 9, no. 3, pp. 148-152, 2012.
18. G. C. Gurtner, S. Werner, Y. Barrandon, and M. T. Longaker, "Wound repair and regeneration, " Nature, vol. 453, no. 7193, pp. 314-321, 2008.
19. J. M. Rhett, G. S. Ghatnekar, J. A. Palatinus, M. OQuinn, M. J. Yost, and R. G.Gourdie, "Novel therapies for scar reduction and regenerative healing of skin wounds, " Trends in Biotechnology, vol. 26, no. 4, pp. 173-180, 2008.
20. R. F. Diegelmann and M. C. Evans, "Wound healing: A n overview of acute, fibrotic and delayed healing, " Frontiers in Bioscience, vol. 9, pp. 283-289, 2004.
21. B. Rybinski, J. Franco-Barraza, and E. Cukierman, "The wound healing, chronic fibrosis, and cancer progression triad, " Physiological Genomics, vol. 46, no. 7, pp. 223-244, 2014.
22. M. R. Namazi, M. K. Fallahzadeh, and R. A. Schwartz, "Strategies for prevention of scars: A what can we learn from fetal skin? International Journal of Dermatology, vol. 50, no. 1, pp. 85-93, 2011.
23. L. Van De Water, S. Varney, and J. J. Tomasek, "Mechanoregulation of the myofibroblast in wound contraction, scarring, and fibrosis: A opportunities for new therapeutic intervention, " Advances inWound Care, vol. 2, no. 4, pp. 122-141, 2013.
24. J. Mann and D. A. Mann, "Epigenetic regulation of wound healing and fibrosis, " Current Opinion in Rheumatology, vol. 25, no. 1, pp. 101-107, 2013.
25. J. S. Duffield, M. Lupher, V. J. Thannickal, and T. A. Wynn, "Host responses in tissue repair and fibrosis, " Annual Review of Pathology: A Mechanisms of Disease, vol. 8, pp. 241-276, 2013.
26. F. Klingberg, B. Hinz, and E. S. White, "The myofibroblast matrix: A Implications for tissue repair and fibrosis, " Journal of Pathology, vol. 229, no. 2, pp. 298-309, 2013.
27. X. Fan and H. Liang, "Criculating fibrocytes: A potent cell population in antigen-presenting and wound healing, " Chinese Journal of Traumatology, vol. 13, no. 2, pp. 111-116, 2010.
28. E. C. Keeley, B. Mehrad, and R. M. Strieter, "The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of fibrotic disorders, " Thrombosis and Haemostasis, vol. 101, no. 4, pp. 613-618, 2009.
29. B. Eyden, "The myofibroblast: A phenotypic characterization as a prerequisite to understand ing its functions in translational medicine, " Journal of Cellular and Molecular Medicine, vol. 12, no. 1, pp. 22-37, 2008.
30. D. Jiang, J. Liang, and P.W. Noble, "Hyaluronan as an immune regulator in human diseases, " Physiological Reviews, vol. 91, no. 1, pp. 221-264, 2011.
31. D. A. Barron and D. R. Rowley, "The reactive stroma microenvironment and prostate cancer progression, " Endocrine-Related Cancer, vol. 19, no. 6, pp. R187-R204, 2012.
32. S. Togo, U. M. Polanska, Y. Horimoto, and A. Orimo, "Carcinoma-associated fibroblasts are a promising therapeutic target, " Cancers, vol. 5, no. 1, pp. 149-169, 2013.
33. Y. Mao, E. T. Keller, D. H. Garfield, K. Shen, and J. Wang, "Stromal cells in tumor microenvironment and breast cancer, " Cancer and Metastasis Reviews, vol. 32, no. 1-2, pp. 303-315, 2013.
34. D. Hanahan and L. M. Coussens, "Accessories to the crime: A functions of cells recruited to the tumor microenvironment, " Cancer Cell, vol. 21, no. 3, pp. 309-322, 2012.
35. C.W.Huo, G. L.Chew, and K. L. Britt, "Mammographic density: A review on the current understand ing of its association with breast cancer, " Breast Cancer Research and Treatment, vol. 144, no. 3, pp. 479-502, 2014.
36. K. Ghosh, K. R. Brandt, C. Reynolds et al., "Tissue composition of mammographically dense and non-dense breast tissue, " Breast Cancer Research and Treatment, vol. 131, no. 1, pp. 267-275, 2012.
37. M. J. Bissell and W. C. Hines, "Why dont we get more cancer? A proposed role of the microenvironment in restraining cancer progression, " Nature Medicine, vol. 17, no. 3, pp. 320-329, 2011.
38. P. J. Keely, "Mechanisms by which the extracellular matrix and integrin signaling act to regulate the switch between tumor suppression and tumor promotion, " Journal of Mammary Gland Biology and Neoplasia, vol. 16, no. 3, pp. 205-219, 2011.
39. J. Paulsson and P. Micke, "Prognostic relevance of cancerassociated fibroblasts in human cancer, " Seminars in Cancer Biology, vol. 25, pp. 61-68, 2014.
40. M. A. Troester, M. H. Lee, M. Carter et al., "Activation of host wound responses in breast cancer microenvironment, " Clinical Cancer Research, vol. 15, no. 22, pp. 7020-7028, 2009.
41. M. H. Manjili, K. Najarian, and X. Wang, "Signatures of tumor-immune interactions as biomarkers for breast cancer prognosis, " Future Oncology, vol. 8, no. 6, pp. 703-711, 2012.
42. S. Ahn, J. Cho, J. Sung et al., "The prognostic significance of tumor-associated stroma in invasive breast carcinoma, " Tumor Biology, vol. 33, no. 5, pp. 1573-1580, 2012.
43. K. Räsänen and A. Vaheri, "Activation of fibroblasts in cancer stroma, " Experimental Cell Research, vol. 316, no. 17, pp. 2713-2722, 2010.
44. G. Xouri and S. Christian, "Origin and function of tumor stroma fibroblasts, " Seminars in Cell and Developmental Biology, vol. 21, no. 1, pp. 40-46, 2010.
45. J. C. Monboisse, J. B. Oudart, L. Ramont, S. Brassart-Pasco, and F. X. Maquart, "Matrikines from basement membrane collagens: A new anti-cancer strategy, " Biochimica et Biophysica Acta, vol. 1840, no. 8, pp. 2589-2598, 2014.
46. F. L.Miles and R. A. Sikes, "Insidious changes in stromal matrix fuel cancer progression, Molecular Cancer Research, vol. 12, no. 3, pp. 297-312, 2014.
47. J. Samples, M. Willis, and N. Klauber-Demore, "Targeting angiogenesis and the tumor microenvironment, " Surgical Oncology Clinics of North America, vol. 22, no. 4, pp. 629-639, 2013.
48. P. Heldin, K. Basu, B. Olofsson, H. Porsch, I. Kozlova, and K. Kahata, "Deregulation of hyaluronan synthesis, degradation and binding promotes breast cancer, " The Journal of Biochemistry, vol. 154, no. 5, pp. 395-408, 2013.
49. C. A. Maxwell, J. Benítez, L. Gómez-Baldó et al., "Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer, " PLoS Biology, vol. 9, no. 11, Article ID e1001199, 2011.
50. A. C. Petrey and C. A. de la Motte, "Hyaluronan, a crucial regulator of inflammation, " Frontiers in Immunology, vol. 5, p. 101, 2014.
51. D. Vigetti, E. Karousou, M. Viola, S. Deleonibus, G. De Luca, and A. Passi, "Hyaluronan: A biosynthesis and signaling, " Biochimica et Biophysica Acta, vol. 1840, no. 8, pp. 2452-2459, 2014.
52. B. P. Toole and M. G. Slomiany, "Hyaluronan: A constitutive regulator of chemoresistance and malignancy in cancer cells, " Seminars in Cancer Biology, vol. 18, no. 4, pp. 244-250, 2008.
53. K. T. Dicker, L. A. Gurski, S. Pradhan-Bhatt, R. L. Witt, M. C. Farach-Carson, and X. Jia, "Hyaluronan: A simple polysaccharide with diverse biological functions, " Acta Biomaterialia, vol. 10, no. 4, pp. 1558-1570, 2014.
54. M. Veiseha, D. H. Kwona, A. D. Borowsky et al., "Cellular heterogeneity profiling by hyaluronan probes reveals an invasive but slow-growing breast tumor subset, " Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 17, pp. E1731-E1739, 2014.
55. C. Tolg, S. R. Hamilton, K. Nakrieko et al., "Rhamm?/? fibroblasts are defective in CD44-mediated ERK1, 2 motogenic signaling, leading to defective skinwound repair, " Journal of Cell Biology, vol. 175, no. 6, pp. 1017-1028, 2006.
56. C. Tolg, P. Telmer, and E. Turley, "Specific sizes of hyaluronan oligosaccharides stimulate fibroblast migration and excisional wound repair, " PLoS ONE, vol. 9, no. 2, Article ID e88479, 2014.
57. X. Ma, J. D. Pearce, D. B. Wilson, W. P. English, M. S. Edwards, and R. L. Geary, "Loss of the hyaluronan receptor RHAMMprevents constrictive artery wall remodeling, " Journal of Vascular Surgery, vol. 59, no. 3, pp. 804-813, 2014.
58. J. P. Foley, D. Lam, H. Jiang et al., "Toll-like receptor 2 (TLR2), transforming growth factor-β, hyaluronan (HA), and receptor for HA-mediated motility (RHAMM) are required for surfactant protein a-stimulated macrophage chemotaxis, " Journal of Biological Chemistry, vol. 287, no.44, pp. 37406-37419, 2012.
59. R. Silverman-Gavrila, L. Silverman-Gavrila, and M. P. Bendeck, "Cell division fidelity is altered during the vascular response to injury: A its novel role in atherosclerosis progression, " The American Journal of Pathology, vol. 182, no. 3, pp. 628-639, 2013.
60. S. Nedvetzki, E. Gonen, N. Assayag et al., "RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: A different interpretation of redundancy, " Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 52, pp. 18081-18086, 2004.
61. C. A. Maxwell, J. McCarthy, and E. Turley, "Cell-surface and mitotic-spindle RHAMM: A moonlighting or dual oncogenic functions? Journal of Cell Science, vol. 121, no. 7, pp. 925-932, 2008.
62. H. Shigeishi, K.Higashikawa, and M. Takechi, "Role of receptor for hyaluronan-mediated motility (RHAMM) in human head and neck cancers, " Journal of Cancer Research and Clinical Oncology, 2014.
63. M. S. Karbownik and J. Z. Nowak, "Hyaluronan: A towards novel anti-cancer therapeutics, " Pharmacological Reports, vol. 65, no. 5, pp. 1056-1074, 2013.
64. D. Nikitovic, K. Kouvidi, N. K. Karamanos, and G. N. Tzanakakis, "The roles of hyaluronan/RHAMM/CD44 and their respective interactions along the insidious pathways of fibrosarcoma progression, " BioMed Research International, vol. 2013, Article ID929531, 12 pages, 2013.
65. B. P. Toole, "Hyaluronan: A from extracellular glue to pericellular cue, " Nature Reviews Cancer, vol. 4, no. 7, pp. 528-539, 2004.
66. D. Jiang, J. Liang, and P.W. Noble, "Hyaluronan in tissue injury and repair, " Annual Review of Cell and Developmental Biology, vol. 23, pp. 435-461, 2007.
67. R. Tammi, S. Pasonen-Seppänen, E. Kolehmainen, and M. Tammi, "Hyaluronan synthase induction and hyaluronan accumulation in mouse epidermis following skin injury, " Journal of Investigative Dermatology, vol. 124, no. 5, pp. 898-905, 2005.
68. K. J. Bai, A. P. Spicer, M. M. Mascarenhas et al., "The role of hyaluronan synthase 3 in ventilator-induced lung injury, " American Journal of Respiratory and Critical CareMedicine, vol. 172, no. 1, pp. 92-98, 2005.
69. S. Karvinen, S. Pasonen-Seppänen, J.M. T. Hyttinen et al., "Keratinocyte growth factor stimulates migration and hyaluronan synthesis in the epidermis by activation of keratinocyte hyaluronan synthases 2 and 3, The Journal of Biological Chemistry, vol. 278, no. 49, pp. 49495-49504, 2003.
70. K. Kuroda, A. Utani, Y. Hamasaki, and H. Shinkai, "Upregulation of putative hyaluronan synthase mRNA by basic fibroblast growth factor and insulin-like growth factor-1 in human skin fibroblasts, " Journal of Dermatological Science, vol. 26, no. 2, pp. 156-160, 2001.
71. J. P. Pienimäki, K. Rilla, C. Fülöp et al., "Epidermal growth factor activates hyaluronan synthase 2 in epidermal keratinocytes and increases pericellular and intracellular hyaluronan, " The Journal of Biological Chemistry, vol. 276, no. 23, pp. 20428-20435, 2001.
72. S. Yung, G. J. Thomas, and M. Davies, "Induction of hyaluronan metabolism after mechanical injury of human peritoneal mesothelial cells in vitro, " Kidney International, vol. 58, no. 5, pp. 1953-1962, 2000.
73. C. I. Kennedy, R. F. Diegelmann, J. H. Haynes, and D. R. Yager, "Proinflammatory cytokines differentially regulate hyaluronan synthase isoforms in fetal and adult fibroblasts, " Journal of Pediatric Surgery, vol. 35, no. 6, pp. 874-879, 2000.
74. P. Auvinen, K. Rilla, R. Tumelius et al., "Hyaluronan synthases (HAS1-3) in stromal and malignant cells correlate with breast cancer grade and predict patient survival, " Breast Cancer Research and Treatment, vol. 143, no. 2, pp. 277-286, 2014.
75. S. Adamia, P.M. Pilarski, A. R. Belch, and L.M. Pilarski, "Aberrant splicing, hyaluronan synthases and intracellular hyaluronan as drivers of oncogenesis and potential drug targets, " Current Cancer Drug Targets, vol. 13, no. 4, pp. 347-361, 2013.
76. R. H. Tammi, A. G. Passi, K. Rilla et al., "Transcriptional and post-translational regulation of hyaluronan synthesis, " FEBS Journal, vol. 278, no. 9, pp. 1419-1428, 2011.
77. T. K. Nykopp, K. Rilla, R. Sironen et al., "Expression of hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1- 2) in serous ovarian carcinomas: A inverse correlation between HYAL1 and hyaluronan content, BMC Cancer, vol. 9, article 143, 2009.
78. N. Itano and K. Kimata, "Altered hyaluronan biosynthesis in cancer progression, " Seminars in Cancer Biology, vol. 18, no. 4, pp. 268-274, 2008.
79. P. E. Pummill and P. L. DeAngelis, "Evaluation of critical structural elements of UDP-sugar substrates and certain cysteine residues of a vertebrate hyaluronan synthase, " The Journal of Biological Chemistry, vol. 277, no. 24, pp. 21610-21616, 2002.
80. F. Bonté, "Skin moisturization mechanisms: A new data, " Annales Pharmaceutiques Francaises, vol. 69, no. 3, pp. 135-141, 2011.
81. R. Stern and H. I. Maibach, "Hyaluronan in skin: A aspects of aging and its pharmacologic modulation, " Clinics in Dermatology, vol. 26, no. 2, pp. 106-122, 2008.
82. S. Verdier-Sévrain and F. Bonté, "Skin hydration: A review on its molecular mechanisms, " Journal of Cosmetic Dermatology, vol. 6, no. 2, pp. 75-82, 2007.
83. T. D. Camenisch, J. Biesterfeldt, T. Brehm-Gibson, J. Bradley, and J. A. McDonald, "Regulation of cardiac cushion development by hyaluronan, " Experimental & Clinical Cardiology, vol. 6, no. 1, pp. 4-10, 2001.
84. T. D. Camenisch, A. P. Spicer, T. Brehm-Gibson et al., "Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme, " Journal of Clinical Investigation, vol. 106, no. 3, pp. 349-360, 2000.
85. V. Goncharova, N. Serobyan, S. Iizuka et al., "Hyaluronan expressed by the hematopoietic microenvironment is required for bone marrow hematopoiesis, " The Journal of Biological Chemistry, vol. 287, no. 30, pp. 25419-25433, 2012.
86. K. Törrönen, K. Nikunen, R. Kärnä, M. Tammi, R. Tammi, and K. Rilla, "Tissue distribution and subcellular localization of hyaluronan synthase isoenzymes, " Histochemistry and Cell Biology, vol. 141, no. 1, pp. 17-31, 2014.
87. J. Y. L. Tien and A. P. Spicer, "Three vertebrate hyaluronan synthases are expressed during mouse development in distinct spatial and temporal patterns, " Developmental Dynamics, vol. 233, no. 1, pp. 130-141, 2005.
88. D. Vigetti, M. Viola, E. Karousou, G. de Luca, and A. Passi, "Metabolic control of hyaluronan synthases, " Matrix Biology, vol. 35, pp. 8-13, 2014.
89. P. L.DeAngelis, "Glycosaminoglycan polysaccharide biosynthesis and production: A today and tomorrow, " AppliedMicrobiology and Biotechnology, vol. 94, no. 2, pp. 295-305, 2012.
90. P. H. Weigel and P. L. DeAngelis, "Hyaluronan synthases: A decade-plus of novel glycosyltransferases, " The Journal of Biological Chemistry, vol. 282, no. 51, pp. 36777-36781, 2007.
91. K. Inai, J. L. Burnside, S. Hoffman, B. P. Toole, and Y. Sugi, "BMP-2 induces versican and hyaluronan that contribute to post-EMT AV cushion cell migration, " PLoS ONE, vol. 8, no. 10, Article ID e77593, 2013.
92. Y. Hirose, E. Saijou, Y. Sugano et al., "Inhibition of Stabilin-2 elevates circulating hyaluronic acid levels and prevents tumor metastasis, " Proceedings of the National Academy of Sciences of theUnited States ofAmerica, vol. 109, no. 11, pp. 4263-4268, 2012.
93. H. C. Lien, Y. H. Lee, Y. M. Jeng, C. H. Lin, Y. S. Lu, and Y. T. Yao, "Differential expression of hyaluronan synthase 2 in breast carcinoma and its biological significance, " Histopathology, 2014.
94. C. I. Kung, C. Chen, C. Yang, C. Lin, T. Chen, and H. Wang, "Enhanced membrane-type 1 matrix metalloproteinase expression by hyaluronan oligosaccharides in breast cancer cells facilitates CD44 cleavage and tumor cell migration, " Oncology Reports, vol. 28, no. 5, pp. 1808-1814, 2012.
95. S. R.Hamilton, S. F. Fard, F. F. Paiwand et al., "The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1, 2 that sustain high basal motility in breast cancer cells, " The Journal of Biological Chemistry, vol. 282, no. 22, pp. 16667-16680, 2007.
96. Z. Wang, Y. Wu, H. Wang et al., "Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility, " Proceedings of theNational Academy of Sciences of the United States of America, vol. 111, no. 1, pp. E89-E98, 2014.
97. R. H. Tammi, A. Kultti, V. Kosma, R. Pirinen, P. Auvinen, and M. I. Tammi, "Hyaluronan in human tumors: A pathobiological and prognostic messages from cell-associated and stromal hyaluronan, " Seminars in Cancer Biology, vol. 18, no. 4, pp. 288-295, 2008.
98. R. Stern, A. A. Asari, and K. N. Sugahara, "Hyaluronan fragments: A n information-rich system, " European Journal of Cell Biology, vol. 85, no. 8, pp. 699-715, 2006.
99. P. L. Bollyky, M. Bogdani, J. B. Bollyky, R. L. Hull, and T. N. Wight, "The role of hyaluronan and the extracellularmatrix in islet inflammation and immune regulation, " Current Diabetes Reports, vol. 12, no. 5, pp. 471-480, 2012.
100. X. Tian, J. Azpurua, C. Hine et al., "High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat, " Nature, vol. 499, no. 7458, pp. 346-349, 2013.
101. P. R. Esser, U. Wölfle, C. Dürr et al., "Contact sensitizers induce skin inflammation via ROS production and hyaluronic acid degradation, " PLoS ONE, vol. 7, no. 7, Article ID e41340, 2012.
102. M. E. Monzon, N. Fregien, N. Schmid et al., "Reactive oxygen species and hyaluronidase 2 regulate airway epithelial hyaluronan fragmentation, " Journal of Biological Chemistry, vol. 285, no. 34, pp. 26126-26134, 2010.
103. F. Gao, J. R. Koenitzer, J. M. Tobolewski et al., "Extracellular superoxide dismutase inhibits inflammation by preventing oxidative fragmentation of hyaluronan, " The Journal of Biological Chemistry, vol. 283, no. 10, pp. 6058-6066, 2008.
104. M. D. Rees, C. L.Hawkins, and M. J. Davies, "Hypochlorite and superoxide radicals can act synergistically to induce fragmentation of hyaluronan and chondroitin sulphates, " Biochemical Journal, vol. 381, part 1, pp. 175-184, 2004.
105. C. C. Termeer, J. Hennies, U. Voith et al., "Oligosaccharides of hyaluronan are potent activators of dendritic cells, " Journal of Immunology, vol. 165, no. 4, pp. 1863-1870, 2000.
106. C. Tolg, S. R. Hamilton, E. Zalinska et al., "A RHAMMmimetic peptide blocks hyaluronan signaling and reduces inflammation and fibrogenesis in excisional skin wounds, " The American Journal of Pathology, vol. 181, no. 4, pp. 1250-1270, 2012.
107. H. Yuan, M. Tank, and A. Alsofyani, "Molecular mass dependence of hyaluronan detection by sand wich ELISA-like assay and membrane blotting using biotinylated hyaluronan binding protein, " Glycobiology, vol. 23, no. 11, pp. 1270-1280, 2013.
108. S. M. Ruppert, T. R. Hawn, A. Arrigoni, T. N. Wight, and P. L. Bollyky, "Tissue integrity signals communicated by highmolecular weight hyaluronan and the resolution of inflammation, " Immunologic Research, vol. 58, no. 2-3, pp. 186-192, 2014.
109. H. Urakawa, Y. Nishida, W. Knudson et al., "Therapeutic potential of hyaluronan oligosaccharides for bone metastasis of breast cancer, " Journal of Orthopaedic Research, vol. 30, no. 4, pp. 662-672, 2012.
110. F. E. Lennon and P. A. Singleton, "Hyaluronan regulation of vascular integrity, " American Journal of Cardiovascular Disease, vol. 1, no. 3, pp. 200-213, 2011.
111. R. D. Price, S. Myers, I. M. Leigh, and H. A. Navsaria, "The role of hyaluronic acid in wound healing: A assessment of clinical evidence, " American Journal of Clinical Dermatology, vol. 6, no. 6, pp. 393-402, 2005.
112. E. Hrabarova, I. Juranek, and L. Soltes, "Pro-oxidative effect of peroxynitrite regarding biological systems: A special focus on high-molar-mass hyaluronan degradation, " General Physiology and Biophysics, vol. 30, no. 3, pp. 223-238, 2011.
113. L. Šoltés, R. Mendichi, G. Kogan, J. Schiller, M. Stankovská, and J. Arnhold, "Degradative action of reactive oxygen species on hyaluronan, " Biomacromolecules, vol. 7, no. 3, pp. 659-668, 2006.
114. K. A. Scheibner, M. A. Lutz, S. Boodoo, M. J. Fenton, J. D. Powell, and M. R. Horton, "Hyaluronan fragments act as an endogenous danger signal by engaging TLR2, " The Journal of Immunology, vol. 177, no. 2, pp. 1272-1281, 2006.
115. C. A. de la Motte, "Hyaluronan in intestinal homeostasis and inflammation: A implications for fibrosis, " American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 301, no. 6, pp. G945-G949, 2011.
116. M. T. Kuipers, T. van der Poll, M. J. Schultz, and C.W.Wieland , "Bench-to-bedside review: A damage-associated molecular patterns in the onset of ventilator-induced lung injury, " Critical Care, vol. 15, no. 6, article 235, 2011.
117. J. D. Powell and M. R. Horton, "Threat matrix: A low-molecularweight hyaluronan (HA) as a danger signal, " Immunologic Research, vol. 31, no. 3, pp. 207-218, 2005.
118. K. Kishi, K. Okabe, R. Shimizu, and Y. Kubota, "Fetal skin possesses the ability to regenerate completely: A Complete regeneration of skin, " Keio Journal of Medicine, vol. 61, no. 4, pp. 101-108, 2012.
119. M. Slevin, J. Krupinski, J. Gaffney et al., "Hyaluronan-mediated angiogenesis in vascular disease: A uncovering RHAMM and CD44 receptor signaling pathways, Matrix Biology, vol. 26, no. 1, pp. 58-68, 2007.
120. T. N. Wight and S. Potter-Perigo, "The extracellularmatrix: A n active or passive player in fibrosis? The American Journal of Physiology - Gastrointestinal and Liver Physiology, vol. 301, no. 6, pp. G950-G955, 2011.
121. D. Jiang, J. Liang, and P.W.Noble, "Regulationof non-infectious lung injury, inflammation, and repair by the extracellularmatrix glycosaminoglycan hyaluronan, " Anatomical Record, vol. 293, no. 6, pp. 982-985, 2010.
122. F. Gao, Y. Liu, Y. He et al., "Hyaluronan oligosaccharides promote excisional wound healing through enhanced angiogenesis, " Matrix Biology, vol. 29, no. 2, pp. 107-116, 2010.
123. F. Gao, C. X. Yang, W.Mo, Y.W. Liu, and Y.Q.He, "Hyaluronan oligosaccharides are potential stimulators to angiogenesis via RHAMM mediated signal pathway in wound healing, " Clinical and Investigative Medicine, vol. 31, no. 3, pp. E106-E116, 2008.
124. U. anderegg, J. C. Simon, and M. Averbeck, "More than just a filler-the role of hyaluronan for skin homeostasis, " Experimental Dermatology, vol. 23, no. 5, pp. 295-303, 2014.
125. A. Moustakas and P. Heldin, "TGFβ and matrix-regulated epithelial to mesenchymal transition, " Biochimica et Biophysica Acta, vol. 1840, no. 8, pp. 2621-2634, 2014.
126. R. Tammi, U. M. Agren, A. L. Tuhkanen, and M. Tammi, "Hyaluronan metabolism in skin, " Progress in Histochemistry and Cytochemistry, vol. 29, no. 2, pp. 1-81, 1994.
127. B. Wang, "Photoaging: A review of current concepts of pathogenesis, " Journal of Cutaneous Medicine and Surgery, vol. 15, supplement 1, pp. S374-S377, 2011.
128. A. Leung, T. M. Crombleholme, and S. G. Keswani, "Fetal wound healing: A Implications for minimal scar formation, " Current Opinion in Pediatrics, vol. 24, no. 3, pp. 371-378, 2012.
129. S. Pasonen-Seppänen, J. M. T. Hyttinen, K. Rilla et al., "Role of CD44 in the organization of keratinocyte pericellular hyaluronan, " Histochemistry and Cell Biology, vol. 137, no. 1, pp. 107-120, 2012.
130. J. Malaisse, V. Bourguignon, E. de Vuyst et al., "Hyaluronan Metabolism in Human Keratinocytes and Atopic Dermatitis Skin Is Driven by a Balance of Hyaluronan Synthases 1 and 3, " Journal of Investigative Dermatology, vol. 134, no. 8, pp. 2174-2182, 2014.
131. M. Kage, Y. Tokudome, Y. Matsunaga, T. Hariya, and F. Hashimoto, "Effect of hyaluronan tetrasaccharides on epidermal differentiation in normal human epidermal keratinocytes, " International Journal of Cosmetic Science, vol. 36, no. 1, pp. 109-115, 2014.
132. H. Choi, Y. Kang, J. Na et al., "Oligosaccharides of hyaluronic acid increased epidermal cell stemness by modulation of integrin expression, " Journal of Cosmetic Dermatology, vol. 11, no. 4, pp. 290-296, 2012.
133. D. Colello, S. Mathew, R. Ward, K. Pumiglia, and S. E. LaFlamme, "Integrins regulate microtubule nucleating activity of centrosome through mitogen-activated protein kinase/ extracellular signal-regulated kinase kinase/extracellular signal- regulated kinase (MEK/ERK) signaling, " The Journal of Biological Chemistry, vol. 287, no. 4, pp. 2520-2530, 2012.
134. R. H. Tammi and M. I. Tammi, "Hyaluronan accumulation in wounded epidermis: A mediator of keratinocyte activation, " The Journal of Investigative Dermatology, vol. 129, no. 8, pp. 1858-1860, 2009.
135. Y. Xu, D. Baker, T. Quan, J. J. Baldassare, J. J. Voorhees, and G. J. Fisher, "Receptor type protein tyrosine phosphatase-κ mediates cross-talk between transforming growth factor-β and epidermal growth factor receptor signaling pathways in human keratinocytes, " Molecular Biology of the Cell, vol. 21, no. 1, pp. 29-35, 2010.
136. M. L. Mancini and S. T. Sonis, "Mechanisms of cellular fibrosis associated with cancer regimen-related toxicities, " Frontiers in Pharmacology, vol. 5, p. 51, 2014.
137. G. S. Ashcroft, X. Yang, A. B. Glick et al., "Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response, " Nature Cell Biology, vol. 1, no. 5, pp. 260-266, 1999.
138. A. C. Midgley, M. Rogers, M. B. Hallett et al., "Transforming growth factor-β1 (TGF-β1)-stimulated fibroblast to myofibroblast differentiation is mediated by hyaluronan (HA)-facilitated epidermal growth factor receptor (EGFR) and CD44 colocalization in lipid rafts, " Journal of Biological Chemistry, vol. 288, no. 21, pp. 14824-14838, 2013.
139. J.Webber, R. H. Jenkins, S.Meran, A. Phillips, and R. Steadman, "Modulation of TGFβ1-dependent myofibroblast differentiation by hyaluronan, TheAmerican Journal of Pathology, vol. 175, no. 1, pp. 148-160, 2009.
140. M. S. Hu, Z. N.Maan, J. C. Wu et al., "Tissue engineering and regenerative repair in wound healing, " Annals of Biomedical Engineering, vol. 42, no. 7, pp. 1494-1507, 2014.
141. C. Zgheib, J. Xu, and K. W. Liechty, "Targeting inflammatory cytokines and extracellular matrix composition to promote wound regeneration, " Advances in Wound Care, vol. 3, no. 4, pp. 344-355, 2014.
142. A. Orimo and R. A.Weinberg, "Stromal fibroblasts in cancer: A novel tumor-promoting cell type, " Cell Cycle, vol. 5, no. 15, pp. 1597-1601, 2006.
143. R. C. Caskey, M.Allukian, R. C. Lindet al., "Lentiviral-mediated over-expression of hyaluronan synthase-1 (HAS-1) decreases the cellular inflammatory response and results in regenerative wound repair, " Cell and Tissue Research, vol. 351, no. 1, pp. 117-125, 2013.
144. M. Prosdocimi and C. Bevilacqua, "Exogenous hyaluronic acid and wound healing: A n updated vision, " Panminerva Medica, vol. 54, no. 2, pp. 129-135, 2012.
145. G. M. Campo, A. Avenoso, A. DAscola et al., "Inhibition of hyaluronan synthesis reduced inflammatory response in mouse synovial fibroblasts subjected to collagen-induced arthritis, " Archives of Biochemistry and Biophysics, vol. 518, no. 1, pp. 42-52, 2012.
146. K. Ghazi, U. Deng-Pichon, J. Warnet, and P. Rat, "Hyaluronan fragments improve wound healing on in vitro cutaneous model through P2X7 purinoreceptor basal activation: A role of molecular weight, " PLoS ONE, vol. 7, no. 11, Article ID e48351, 2012.
147. C. de La Motte, J. Nigro, A. Vasanji et al., "Plateletderived hyaluronidase 2 cleaves hyaluronan into fragments that trigger monocyte-mediated production of proinflammatory cytokines, " American Journal of Pathology, vol. 174, no. 6, pp. 2254-2264, 2009.
148. E. L. Ferguson, J. L. Roberts, R. Moseley, P. C. Griffiths, and D.W. Thomas, "Evaluation of the physical and biological properties of hyaluronan and hyaluronan fragments, " International Journal of Pharmaceutics, vol. 420, no. 1, pp. 84-92, 2011.
149. M. David-Raoudi, F. Tranchepain, B. Deschrevel et al., "Differential effects of hyaluronan and its fragments on fibroblasts: A relation to wound healing, " Wound Repair and Regeneration, vol. 16, no. 2, pp. 274-287, 2008.
150. G. Kaya, C. Tran, O. Sorg et al., "Hyaluronate fragments reverse skin atrophy by a CD44-dependent mechanism, " PLoS Medicine, vol. 3, no. 12, article e493, pp. 2291-2303, 2006.
151. M. Wernicke, L. C. Piñeiro, D. Caramutti et al., "Breast cancer stromalmyxoid changes are associatedwith tumor invasionand metastasis: A central role for hyaluronan, " Modern Pathology, vol. 16, no. 2, pp. 99-107, 2003.
152. Y. Takahashi, H. Kuwabara, M. Yoneda, Z. Isogai, N. Tanigawa, and Y. Shibayama, "Versican G1 and G3 domains are upregulated and latent transforming growth factor-β binding protein- 4 is downregulated in breast cancer stroma, " Breast Cancer, vol. 19, no. 1, pp. 46-53, 2012.
153. D. E. Costea, A. Hills, A. H. Osman et al., "Identification of two distinct carcinoma-associated fibroblast subtypes with differential tumor-promoting abilities in oral squamous cell carcinoma, " Cancer Research, vol. 73, no. 13, pp. 3888-3901, 2013.
154. H. Koyama, T. Hibi, Z. Isogai et al., "Hyperproduction of hyaluronan in Neu-induced mammary tumor accelerates angiogenesis through stromal cell recruitment: A Possible involvement of versican/PG-M, " The American Journal of Pathology, vol. 170, no. 3, pp. 1086-1099, 2007.
155. H. Koyama, N. Kobayashi, M. Harada et al., "Significance of tumor-associated stroma in promotion of intratumoral lymphangiogenesis: A pivotal role of a hyaluronan-rich tumor microenvironment, " American Journal of Pathology, vol. 172, no. 1, pp. 179-193, 2008.
156. P. Bono, V. Wasenius, P.Heikkilä, J. Lundin, D. G. Jackson, and H. Joensuu, "High LYVE-1-positive lymphatic vessel numbers are associated with poor outcome in breast cancer, " Clinical Cancer Research, vol. 10, no. 21, pp. 7144-7149, 2004.
157. N. Kobayashi, S. Miyoshi, T. Mikami et al., "Hyaluronan deficiency in tumor stroma impairsmacrophage trafficking and tumor neovascularization, " Cancer Research, vol. 70, no. 18, pp. 7073-7083, 2010.
158. P. Auvinen, R. Tammi, V. Kosma et al., "Increased hyaluronan content and stromal cell CD44 associate with HER2 positivity and poor prognosis in human breast cancer, " International Journal of Cancer, vol. 132, no. 3, pp. 531-539, 2013.
159. J. I. Lopez, T. D. Camenisch, M. V. Stevens, B. J. Sands, J. McDonald, and J. A. Schroeder, "CD44 attenuates metastatic invasion during breast cancer progression, " Cancer Research, vol. 65, no. 15, pp. 6755-6763, 2005.
160. J. M. V. Louderbough and J. A. Schroeder, "Understand ing the dual nature of CD44 in breast cancer progression, " Molecular Cancer Research, vol. 9, no. 12, pp. 1573-1586, 2011.
161. N. Montgomery, A. Hill, S. McFarlane et al., "CD44 enhances invasion of basal-like breast cancer cells by upregulating serine protease and collagen-degrading enzymatic expression and activity, " Breast Cancer Research, vol. 14, no. 3, article R84, 2012.
162. V. Joukov, A. C. Groen, T. Prokhorova et al., "The BRCA1/BARD1 heterodimer modulates ran-dependent mitotic spindle assembly, " Cell, vol. 127, no. 3, pp. 539-552, 2006.
163. C. Hardwick, K. Hoare, R. Owens et al., "Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility, " Journal of Cell Biology, vol. 117, no. 6, pp. 1343-1350, 1992.
164. B. Yang, L. Zhang, and E. A. Turley, "Identification of two hyaluronan-binding domains in the hyaluronan receptor RHAMM, " The Journal of Biological Chemistry, vol. 268, no. 12, pp. 8617-8623, 1993.
165. C. Tolg, S. R. Hamilton, L. Morningstar et al., "RHAMM promotes interphase microtubule instability and mitotic spindle integrity through MEK1/ERK1/2 activity, " The Journal of Biological Chemistry, vol. 285, no. 34, pp. 26461-26474, 2010.
166. C. A. Maxwell, J. J. Keats, A. R. Belch, L. M. Pilarski, and T. Reiman, "Receptor for hyaluronan-mediatedmotility correlates with centrosome abnormalities inmultiplemyeloma and maintains mitotic integrity, " Cancer Research, vol. 65, no. 3, pp. 850-860, 2005.
167. R. Forteza, T. Lieb, T. Aoki, R. C. Savani, G. E. Conner, and M. Salathe, "Hyaluronan serves a novel role in airwaymucosal host defense, " The FASEB Journal, vol. 15, no. 12, pp. 2179-2186, 2001.
168. M. Schoenfelder and R. Einspanier, "Expression of hyaluronan synthases and corresponding hyaluronan receptors is differentially regulated during oocyte maturation in cattle, " Biology of Reproduction, vol. 69, no. 1, pp. 269-277, 2003.
169. B. S. Kornovski, J. McCoshen, J.Kredentser, and E.Turley, "The regulation of sperm motility by a novel hyaluronan receptor, " Fertility and Sterility, vol. 61, no. 5, pp. 935-940, 1994.
170. D. Park, Y. Kim, H. Kim et al., "Hyaluronic acid promotes angiogenesis by inducing RHAMM-TGFβ receptor interaction via CD44-PKCδ, " Molecules and Cells, vol. 33, no. 6, pp. 563-574, 2012.
171. D. Manzanares, M. Monzon, R. C. Savani, and M. Salathe, "Apical oxidative hyaluronan degradation stimulates airway ciliary beating via RHAMM and RON, " The American Journal of Respiratory Cell and Molecular Biology, vol. 37, no. 2, pp. 160-168, 2007.
172. F. M. Amara, J. Entwistle, T. I. Kuschak, E. A. Turley, and J. A. Wright, "Transforming growth factor-β1 stimulates multiple protein interactions at a unique cis-element in the 3′-untranslated region of the hyaluronan receptor RHAMM mRNA, The Journal of Biological Chemistry, vol. 271, no. 25, pp. 15279-15284, 1996.
173. S. K. Samuel, R. A. R. Hurta, M. A. Spearman, J. A. Wright, E. A. Turley, and A. H. Greenberg, "TGF-β1 stimulation of cell locomotion utilizes the hyaluronan receptor RHAMM and hyaluronan, " Journal of Cell Biology, vol. 123, no. 3, pp. 749-758, 1993.
174. Y. Buganim and V. Rotter, "RHAMM in the complex p53 cell cycle network, " Cell Cycle, vol. 7, no. 21, pp. 3287-3291, 2008.
175. S. Godar and R. A.Weinber, "Filling the mosaic of p53 actions: A p53 represses RHAMM expression, " Cell Cycle, vol. 7, no. 22, p. 3479, 2008.
176. S. Sohr and K. Engeland , "RHAMMis differentially expressed in the cell cycle and downregulated by the tumor suppressor p53, " Cell Cycle, vol. 7, no. 21, pp. 3448-3460, 2008.
177. C. Tolg, R. Poon, R. Fodde, E. A. Turley, and B. A. Alman, "Genetic deletion of receptor for hyaluronan-mediatedmotility (Rhamm) attenuates the formation of aggressive fibromatosis (desmoid tumor), " Oncogene, vol. 22, no. 44, pp. 6873-6882, 2003.
178. J. Greiner, A. Schmitt, K. Giannopoulos et al., "High-dose RHAMM-R3 peptide vaccination for patients with acute myeloid leukemia, myelodysplastic syndrome and multiple myeloma, " Haematologica, vol. 95, no. 7, pp. 1191-1197, 2010.
179. M. Schmitt, A. Schmitt, M. T. Rojewski et al., "RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma elicits immunologic and clinical responses, " Blood, vol. 111, no. 3, pp. 1357-1365, 2008.
180. T. C. Smith, Z. Fang, and E. J. Luna, "Novel interactors and a role for Supervillin in early cytokinesis, " Cytoskeleton, vol. 67, no. 6, pp. 346-364, 2010.
181. R. C. Savani, C. Wang, B. Yang et al., "Migration of bovine aortic smooth muscle cells after wounding injury. The role of hyaluronan and RHAMM, " Journal of Clinical Investigation, vol. 95, no. 3, pp. 1158-1168, 1995.
182. S. Zhang, M. C. Y. Chang, D. Zylka, S. Turley, R. Harrison, and E. A. Turley, "The hyaluronan receptor RHAMM regulates extracellular-regulated kinase, " Journal of Biological Chemistry, vol. 273, no. 18, pp. 11342-11348, 1998.
183. H. Hatano, H. Shigeishi, Y. Kudo et al., "RHAMM/ERK interaction induces proliferative activities of cementifying fibroma cells through amechanism based on the CD44-EGFR, " Laboratory Investigation, vol. 91, no. 3, pp. 379-391, 2011.
184. Y. N. Du, C. Chou, D. S. Klimstra, and H. Varmus, "Receptor for hyaluronan-mediated motility isoform B promotes liver metastasis in a mouse model of multistep tumorigenesis and a tail vein assay for metastasis, " Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 40, pp. 16753-16758, 2011.
185. R. C. Savani, G. Cao, P. M. Pooler, A. Zaman, Z. Zhou, and H. M. DeLisser, "Differential involvement of the hyaluronan (HA) receptors CD44 and receptor forHA-mediatedmotility in endothelial cell function and angiogenesis, " Journal of Biological Chemistry, vol. 276, no. 39, pp. 36770-36778, 2001.
186. V. B. Lokeshwar and M. G. Selzer, "Differences in hyaluronic acid-mediated functions and signaling in arterial, microvessel, and vein-derived human endothelial cells, " Journal of Biological Chemistry, vol. 275, no. 36, pp. 27641-27649, 2000.
187. C. L. Hall, F. S. Wang, and E. A. Turley, "Src-/- fibroblasts are defective in their ability to disassemble focal adhesions in response to phorbol ester/hyaluronan treatment, " Cell Communication and Adhesion, vol. 9, no. 5-6, pp. 273-283, 2002.
188. K. Kouvidi, A. Berdiaki, D. Nikitovic et al., "Role of receptor for hyaluronic acid-mediated motility (RHAMM) in low molecular weight hyaluronan (LMWHA)-mediated fibrosarcoma cell adhesion, " Journal of Biological Chemistry, vol. 286, no. 44, pp. 38509-38520, 2011.
189. S. Mohapatra, X. Yang, J. A. Wright, E. A. Turley, and A. H. Greenberg, "Soluble hyaluronan receptor RHAMM induces mitotic arrest by suppressing Cdc2 and cyclin B1 expression, " The Journal of Experimental Medicine, vol. 183, no. 4, pp. 1663-1668, 1996.
190. P. E. A. Telmer, "RHAMM is required for MMP-9 expression and release from podosomes 10, " submitted, 2014.
191. A. C. Groen, L. A. Cameron, M. Coughlin, D. T. Miyamoto, T. J. Mitchison, and R. Ohi, "XRHAMM functions in rand ependent microtubule nucleation and pole formation during anastral spindle assembly, " Current Biology, vol. 14, no. 20, pp. 1801-1811, 2004.
192. H. Chen, P. Mohan, J. Jiang et al., "Spatial regulation of Aurora A activity during mitotic spindle assembly requires RHAMM to correctly localize TPX2, " Cell Cycle, vol. 13, no. 14, pp. 2248-2261, 2014.
193. T. C. Smith, P. C. Fridy, Y. Li et al., "Supervillin binding to myosin II and synergism with anillin are required for cytokinesis, " Molecular Biology of the Cell, vol. 24, no. 23, pp. 3603-3619, 2013.
194. S. S. Gangopadhyay, N. Takizawa, C. Gallant et al., "Smooth muscle archvillin: A novel regulator of signaling and contractility in vascular smooth muscle, " Journal of Cell Science, vol. 117, no. 21, pp. 5043-5057, 2004.
195. H. Hasegawa, T. Hyodo, E. Asano et al., "The role of PLK1- phosphorylated SVIL in myosin II activation and cytokinetic furrowing, " Journal of Cell Science, vol. 126, no. 16, pp. 3627-3637, 2013.
196. R. E. Harrison and E. A. Turley, "Active erk regulates microtubule stability inH-ras-transformed cells, " Neoplasia, vol. 3, no. 5, pp. 385-394, 2001.
197. R. Silverman-Gavrila, L. Silverman-Gavrila, G.Hou, M. Zhang, M. Charlton, and M. P. Bendeck, "Rear polarization of the microtubule-organizing center in neointimal smooth muscle cells depends on PKCδ, ARPC5, and RHAMM, " The American Journal of Pathology, vol. 178, no. 2, pp. 895-910, 2011.
198. Y. Gouëffic, C. Guilluy, P. Guérin, P. Patra, P. Pacaud, and G. Loirand , "Hyaluronan induces vascular smooth muscle cell migration through RHAMM-mediated PI3K-dependent Rac activation, " Cardiovascular Research, vol. 72, no. 2, pp. 339-348, 2006.
199. S. P. Evanko, T. Parks, and T. N. Wight, "Intracellular hyaluronan in arterial smooth muscle cells: A association with microtubules, RHAMM, and the mitotic spindle, " Journal of Histochemistry and Cytochemistry, vol. 52, no. 12, pp. 1525-1535, 2004.
200. P. Bhatia, M.Menigatti, M. Brocard, S. Morley, and S. Ferrari, "Mitotic DNA damage targets the Aurora A/TPX2 complex, " Cell Cycle, vol. 9, no. 22, pp. 4592-4599, 2010.
201. P. G. Telmer, C. Tolg, J. B. McCarthy, and E. A. Turley, "How does a protein with dual mitotic spindle and extracellularmatrix receptor functions affect tumor susceptibility and progression? Communicative and Integrative Biology, vol. 4, no. 2, pp. 182-185, 2011.
202. C. A. Maxwell, E. Rasmussen, F. Zhan et al., "RHAMM expression and isoform balance predict aggressive disease and poor survival in multiple myeloma, " Blood, vol. 104, no. 4, pp. 1151-1158, 2004.
203. R. Zhou, X. Wu, and O. Skalli, "The hyaluronan receptor RHAMM/IHABP in astrocytoma cells: A Expression of a tumorspecific variant and association with microtubules, " Journal of Neuro-Oncology, vol. 59, no. 1, pp. 15-26, 2002.
204. B. D. Lynn, X. Li, P. A. Cattini, E. A. Turley, and J. I. Nagy, "Identification of sequence, protein isoforms, and distribution of the hyaluronan-binding protein RHAMM in adult and developing rat brain, " Journal of Comparative Neurology, vol. 439, no. 3, pp. 315-330, 2001.
205. M. Crainie, A. R. Belch, M. J. Mant, and L. M. Pilarski, "Overexpression of the receptor for hyaluronan-mediated motility (RHAMM) characterizes the malignant clone in multiple myeloma: A identification of three distinct RHAMM variants, " Blood, vol. 93, no. 5, pp. 1684-1696, 1999.
206. P. Mohan, J. Castellsague, J. Jiang et al., "Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition, " Oncotarget, vol. 4, no. 1, pp. 80-93, 2013.
207. V. Assmann, D. Jenkinson, J. F. Marshall, and I. R. Hart, "The intracellular hyaluronan receptor RHAMM/IHABP interacts with microtubules and actin filaments, " Journal of Cell Science, vol. 112, part 22, pp. 3943-3954, 1999.
208. A. K. Dunsch, D. Hammond, J. Lloyd, L. Schermelleh, U. Gruneberg, and F. A. Barr, "Dynein light chain 1 and a spindleassociated adaptor promote dynein asymmetry and spindle orientation, " Journal of Cell Biology, vol. 198, no. 6, pp. 1039-1054, 2012.
209. A. Zaman, Z. Cui, J. P. Foley et al., "Expression and role of the hyaluronan receptor RHAMMin inflammation after bleomycin injury, The American Journal of Respiratory Cell and Molecular Biology, vol. 33, no. 5, pp. 447-454, 2005.
210. F. E. Lennon and P. A. Singleton, "Role of hyaluronan and hyaluronan-binding proteins in lung pathobiology, " American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 301, no. 2, pp. L137-L147, 2011.
211. S.Matou-Nasri, J. Gaffney, S. Kumar, and M. Slevin, "Oligosaccharides of hyaluronan induce angiogenesis through distinct CD44 and RHAMM-mediated signalling pathways involving Cdc2 and γ-adducin, " International Journal of Oncology, vol. 35, no. 4, pp. 761-773, 2009.
212. H.N. Lovvorn III, D. L. Cass, K. G. Sylvester et al., "Hyaluronan receptor expression increases in fetal excisional skin wounds and correlates with fibroplasia, " Journal of Pediatric Surgery, vol. 33, no. 7, pp. 1062-1070, 1998.
213. K. K. Mantripragada, G. Spurlock, L. Kluwe et al., "Highresolution DNA copy number profiling ofmalignant peripheral nerve sheath tumors using targeted microarray-based comparative genomic hybridization, " Clinical Cancer Research, vol. 14, no. 4, pp. 1015-1024, 2008.
214. Y. Shi, T. Reiman, W. Li et al., "Targeting aurora kinases as therapy in multiple myeloma, " Blood, vol. 109, no. 9, pp. 3915-3921, 2007.
215. J. Tilghman, H. Wu, Y. Sang et al., "HMMR maintains the stemness and tumorigenicity of glioblastoma stem-like cells, " Cancer Research, vol. 74, no. 11, pp. 3168-3179, 2014.
216. A. E. Rizzardi, N. K. Rosener, J. S. Koopmeiners et al., "Evaluation of protein biomarkers of prostate cancer aggressiveness, " BMC Cancer, vol. 14, no. 1, article 244, 2014.
217. A. E. Rizzardi, R. Vogel, J. S. Koopmeiners et al., "Elevated hyaluronan and hyaluronan-mediated motility receptor are associated with biochemical failure in patients with intermediate-grade prostate tumors, " Cancer, vol. 120, no. 12, pp. 1800-1809, 2014.
218. C.Wang, A. D. Thor, D. H.Moore II et al., "The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression, " Clinical Cancer Research, vol. 4, no. 3, pp. 567-576, 1998.